Publication Information

{'id': 'https://openalex.org/W1994870822', 'doi': 'https://doi.org/10.1097/00007691-200502000-00019', 'title': 'Serum Concentrations of Risperidone and 9-Hydroxyrisperidone After Administration of the Long-Acting Injectable Form of Risperidone', 'display_name': 'Serum Concentrations of Risperidone and 9-Hydroxyrisperidone After Administration of the Long-Acting Injectable Form of Risperidone', 'publication_year': 2005, 'publication_date': '2005-01-21', 'ids': {'openalex': 'https://openalex.org/W1994870822', 'doi': 'https://doi.org/10.1097/00007691-200502000-00019', 'mag': '1994870822', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15665755'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00007691-200502000-00019', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S179268941', 'display_name': 'Therapeutic Drug Monitoring', 'issn_l': '0163-4356', 'issn': ['0163-4356', '1536-3694'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5015474937', 'display_name': 'Ingrid Castberg', 'orcid': 'https://orcid.org/0000-0003-1400-6545'}, 'institutions': [{'id': 'https://openalex.org/I4210104358', 'display_name': "St Olav's University Hospital", 'ror': 'https://ror.org/01a4hbq44', 'country_code': 'NO', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210104358']}], 'countries': ['NO'], 'is_corresponding': False, 'raw_author_name': 'Ingrid Castberg', 'raw_affiliation_strings': ['the Department of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway.'], 'affiliations': [{'raw_affiliation_string': 'the Department of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway.', 'institution_ids': ['https://openalex.org/I4210104358']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5031025442', 'display_name': 'Olav Spigset', 'orcid': 'https://orcid.org/0000-0001-7902-9014'}, 'institutions': [{'id': 'https://openalex.org/I4210104358', 'display_name': "St Olav's University Hospital", 'ror': 'https://ror.org/01a4hbq44', 'country_code': 'NO', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210104358']}], 'countries': ['NO'], 'is_corresponding': False, 'raw_author_name': 'Olav Spigset', 'raw_affiliation_strings': ['the Department of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway.'], 'affiliations': [{'raw_affiliation_string': 'the Department of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway.', 'institution_ids': ['https://openalex.org/I4210104358']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.088, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 43, 'citation_normalized_percentile': {'value': 0.938989, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '27', 'issue': '1', 'first_page': '103', 'last_page': '106'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11943', 'display_name': 'Pharmacovigilance and Adverse Drug Reactions', 'score': 0.9959, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10094', 'display_name': 'Epilepsy research and treatment', 'score': 0.9913, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/dopamine-antagonist', 'display_name': 'Dopamine antagonist', 'score': 0.56952393}, {'id': 'https://openalex.org/keywords/active-metabolite', 'display_name': 'Active metabolite', 'score': 0.52597064}], 'concepts': [{'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.98054796}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.61901844}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.61674446}, {'id': 'https://openalex.org/C2777056448', 'wikidata': 'https://www.wikidata.org/wiki/Q285166', 'display_name': 'Oral administration', 'level': 2, 'score': 0.58177954}, {'id': 'https://openalex.org/C2781353949', 'wikidata': 'https://www.wikidata.org/wiki/Q3271533', 'display_name': 'Dopamine antagonist', 'level': 4, 'score': 0.56952393}, {'id': 'https://openalex.org/C149151106', 'wikidata': 'https://www.wikidata.org/wiki/Q4677569', 'display_name': 'Active metabolite', 'level': 3, 'score': 0.52597064}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5128684}, {'id': 'https://openalex.org/C2777477808', 'wikidata': 'https://www.wikidata.org/wiki/Q407595', 'display_name': 'Metabolite', 'level': 2, 'score': 0.4252854}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3297525}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.1663104}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.14275265}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.06800908}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D016903', 'descriptor_name': 'Drug Monitoring', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D007273', 'descriptor_name': 'Injections, Intramuscular', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016903', 'descriptor_name': 'Drug Monitoring', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068882', 'descriptor_name': 'Paliperidone Palmitate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00007691-200502000-00019', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S179268941', 'display_name': 'Therapeutic Drug Monitoring', 'issn_l': '0163-4356', 'issn': ['0163-4356', '1536-3694'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15665755', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.82, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 15, 'referenced_works': ['https://openalex.org/W1970754447', 'https://openalex.org/W1973870546', 'https://openalex.org/W2003056444', 'https://openalex.org/W2012554561', 'https://openalex.org/W2037507227', 'https://openalex.org/W2041253701', 'https://openalex.org/W2055609884', 'https://openalex.org/W2059314112', 'https://openalex.org/W2064851427', 'https://openalex.org/W2066528005', 'https://openalex.org/W2085696296', 'https://openalex.org/W2103760710', 'https://openalex.org/W2119650801', 'https://openalex.org/W2319976610', 'https://openalex.org/W4295677733'], 'related_works': ['https://openalex.org/W2582322678', 'https://openalex.org/W2395837122', 'https://openalex.org/W2142346783', 'https://openalex.org/W2114321573', 'https://openalex.org/W2100740897', 'https://openalex.org/W2072172265', 'https://openalex.org/W2057787401', 'https://openalex.org/W2044607430', 'https://openalex.org/W2035115059', 'https://openalex.org/W1536088879'], 'abstract_inverted_index': {'There': [0], 'is': [1], 'limited': [2], 'documentation': [3], 'on': [4, 164], 'the': [5, 23, 35, 70, 72, 162, 167, 175, 195, 200, 211, 215, 232, 241, 248], 'pharmacokinetics': [6], 'of': [7, 17, 25, 65, 69, 85, 93, 105, 118, 127, 136, 146, 190, 236, 243], 'long-acting': [8], 'intramuscular': [9, 41, 116, 227], 'risperidone': [10, 26, 98, 106, 155, 237], 'in': [11, 44, 194, 210], 'a': [12, 45, 91, 115, 125, 134, 144], 'naturalistic': [13], 'setting.': [14, 50], 'The': [15, 101, 150], 'objective': [16], 'this': [18], 'study': [19], 'was': [20, 158, 171], 'to': [21, 183, 213, 219, 226, 230], 'investigate': [22], 'concentrations': [24, 104, 235], 'and': [27, 58, 140], 'its': [28], 'active': [29], 'metabolite': [30], '9-hydroxyrisperidone': [31, 108], 'as': [32, 34], 'well': [33], 'concentration/dose': [36], '(C/D)': [37], 'ratios': [38], 'achieved': [39], 'after': [40, 81, 114, 124, 133, 143], 'depot': [42, 63, 184, 228], 'administration': [43, 84, 229], 'routine': [46], 'therapeutic': [47, 258], 'drug': [48, 259], 'monitoring': [49, 260], 'Thirty': [51], 'samples': [52], 'were': [53, 99, 109], 'collected': [54], 'from': [55, 90, 224], '10': [56], 'female': [57], '20': [59], 'male': [60], 'patients': [61, 95, 177], 'receiving': [62], 'injections': [64, 185], 'risperidone.': [66, 86], 'For': [67], '6': [68, 176], 'patients,': [71], 'results': [73], 'could': [74], 'be': [75, 220, 254, 262], 'compared': [76], 'with': [77], 'corresponding': [78], 'data': [79, 89, 202], 'available': [80], 'previous': [82], 'oral': [83, 97, 165, 180, 225], 'In': [87, 161, 174, 198], 'addition,': [88], 'group': [92, 163], '278': [94], 'using': [96, 179], 'retrieved.': [100], 'median': [102, 151, 168], 'serum': [103, 234], 'plus': [107, 156, 238], '38': [110], 'nmol/L': [111, 123, 132, 142], '12-14': [112], 'days': [113], 'dose': [117, 126, 135, 145, 217, 244], '25': [119], 'mg/14': [120, 129, 138, 148], 'days,': [121, 130, 139], '67': [122], '37.5': [128], '99': [131], '50': [137], '148': [141], '75': [147], 'days.': [149], 'C/D': [152, 169, 196], 'ratio': [153, 170], 'for': [154, 247], '9-hydroxy-risperidone': [157], '22.2': [159], '(nmol/L)/(mg/d).': [160, 173], 'medication,': [166], '18.6': [172], 'previously': [178], 'risperidone,': [181], 'switching': [182, 223], 'gave': [186], 'an': [187], 'average': [188], 'increase': [189], '33%': [191], '(range': [192], '12%-68%)': [193], 'ratio.': [197], 'conclusion,': [199], "authors'": [201], 'indicate': [203], 'that': [204], 'there': [205], 'are': [206], 'great': [207], 'interindividual': [208], 'differences': [209], 'extent': [212], 'which': [214], 'daily': [216], 'has': [218], 'reduced': [221], 'when': [222], 'achieve': [231], 'same': [233], '9-hydroxyrisperidone.': [239], 'Because': [240], 'degree': [242], 'adjustment': [245], 'required': [246], 'individual': [249], 'patient': [250], 'so': [251], 'far': [252], 'cannot': [253], 'predicted,': [255], 'guidance': [256], 'by': [257], 'might': [261], 'helpful.': [263]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1994870822', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 5}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-12-13T07:48:48.999929', 'created_date': '2016-06-24'}